Methotrexate for maintenance of remission in ulcerative colitis - Wikidata - awgldk - TriplyDB

Methotrexate for maintenance of remission in ulcerative colitis

Methotrexate for maintenance of remission in ulcerative colitis

http://www.wikidata.org/entity/Q24240019

about

Anti-MAdCAM antibody for induction of remission in ulcerative colitis Methotrexate for maintenance of remission in ulcerative colitis 5-ASA Dose-Response: Maximizing Efficacy and Adherence.Efficacy of methotrexate in ulcerative colitis: failure or promise.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Second Korean guidelines for the management of ulcerative colitis.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

P2860

Q24187593-DDEAC00F-8715-49DE-A80B-0BA82AAFD2DA Q24187928-A3024C00-F739-4E45-AAF4-E8ED52BEDEE5 Q33916329-1D70FEF9-168A-4D89-9D58-3A666C081ECA Q34005379-25F964B1-CEDB-49C5-8217-1415EE091F48 Q35155913-C7120E6E-D689-41A2-B649-EDCCB2777C2B Q37662503-CC4D7D13-9ECD-462A-86AA-76B0A7652CEF Q38191583-C4D4FD9C-C208-4B48-B5BD-513AD217EAB0

P2860

Methotrexate for maintenance of remission in ulcerative colitis

http://www.wikidata.org/entity/Q24240019

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Methotrexate for maintenance of remission in ulcerative colitis

@ast

Methotrexate for maintenance of remission in ulcerative colitis

@en

Methotrexate for maintenance of remission in ulcerative colitis

@en-gb

Methotrexate for maintenance of remission in ulcerative colitis

@nl

type

label

Methotrexate for maintenance of remission in ulcerative colitis

@ast

Methotrexate for maintenance of remission in ulcerative colitis

@en

Methotrexate for maintenance of remission in ulcerative colitis

@en-gb

Methotrexate for maintenance of remission in ulcerative colitis

@nl

prefLabel

Methotrexate for maintenance of remission in ulcerative colitis

@ast

Methotrexate for maintenance of remission in ulcerative colitis

@en

Methotrexate for maintenance of remission in ulcerative colitis

@en-gb

Methotrexate for maintenance of remission in ulcerative colitis

@nl

P1433

Q24240019-D372C33E-B4CB-407E-8BE0-101314E57276

P1476

Q24240019-74C1F59F-C082-4A8A-9D1D-E7D8794E9C2E

P2093

Q24240019-08EB4B26-C0E6-4258-B5CD-0A5ABD5B04C2

Q24240019-D0BCF98D-78A5-474B-8C03-2F563FB11CBD

P2860

Q24240019-1CBF44C1-DF0C-4314-B33C-8FBDEA6C056F

Q24240019-429DF23A-D5E4-464D-A9FE-645BDE045E6E

Q24240019-59C49D91-9DF8-446D-9B29-DF80F7F0A62A

Q24240019-725BBD3A-B405-4179-8E1D-15634C3583AD

Q24240019-97555698-AC3E-448E-80BC-348C276A06F1

Q24240019-9969E2AF-AC59-4458-B8D2-8EF52546569A

Q24240019-B0E0EA7C-ED66-4EE1-878D-4688F387229C

Q24240019-C013C495-E4BB-4B96-AAF6-62BBBB10F579

Q24240019-CB1CE767-BCE7-4059-978C-5FC7DA326929

Q24240019-CB91272E-21F2-461D-BE99-E927349E40B1

P304

Q24240019-5EF9028D-19C8-4642-B0FC-7D8422371A68

P31

Q24240019-A57B0314-7E9F-43ED-B2BE-5C61AC80C450

P356

Q24240019-42557B5B-BD8E-410D-BE34-4E3162362C07

P433

Q24240019-444B75E5-FD32-466F-A853-EACF4926A98A

P50

Q24240019-5C0E9438-3334-41B4-BA0B-0E12594CD431

P577

Q24240019-6250EBB4-87B5-4318-9686-10CE1F48A0FB

P698

Q24240019-F89FCFEE-4743-452E-9BF1-E79B0EA52600

P356

14651858.CD007560.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Methotrexate for maintenance of remission in ulcerative colitis

@en

P2093

Anne Marie Griffiths

http://www.w3.org/2001/XMLSchema#string

Ben Vandermeer

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.

Methotrexate: first-line or second-line immunomodulator?

Experience with the use of low-dose methotrexate for inflammatory bowel disease.

Review article: the management of steroid dependency in ulcerative colitis.

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects.

Low-dose oral methotrexate in refractory inflammatory bowel disease.

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.

The pharmacogenetics of methotrexate in inflammatory bowel disease.

P304

CD007560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD007560.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19588435

http://www.w3.org/2001/XMLSchema#string